Qualcomm asks a jury to let it stop paying Arm royalties for five years

Qualcomm opened a five-day Delaware trial asking a jury to let it stop paying royalties to Arm for up to five years, a remedy potentially worth billions. The pricing power the case tests is the same story that has more than doubled ARM's stock this year.

In this storyARMQCOMMETA
Vincent JiangVincent Jiang · 2 min read
Share
Cristiano Amon, chief executive of Qualcomm, speaking on stage
1 / 6Slide 1 of 6
Qualcomm chief executive Cristiano Amon testified in the Delaware trial this week

Qualcomm asks to stop paying Arm for five years

Qualcomm and Arm opened a five-day jury trial in Wilmington, Delaware, on October 5, with Qualcomm asking for the right to stop paying royalties to Arm for up to five years, a remedy potentially worth billions 1. Judge Maryellen Noreika is weighing whether to throw that term of the contract out first, which would leave Qualcomm chasing a smaller claim 12. A parallel bench trial asks whether Arm negotiated in good faith over version 10 of its architecture, under an agreement that runs to 2033 1.

A $1.88 cap meets a 288-core chip

Qualcomm's attorney kept returning to a chart showing Arm seeking a 1,800% royalty increase between version 9 and version 10 of its computing architecture 1. Arm's attorney pressed chief executive Cristiano Amon on the 2013 license that caps royalties at $1.88 per chip for any chip with five or more processor cores: with data-center chips now carrying 288 cores, was Qualcomm paying for five and "getting 283 for free"? 1 "I don't see it that way," Amon said 1. The fight is a smartphone-era contract being asked to price data-center silicon.

Arm's answer: Meta moved on, and no harm done

Qualcomm's Karen Dunn told jurors Arm leaked its 2024 breach notice to the press, and that by the time Qualcomm secured its Meta chip deal the value had fallen by $170 million: "Delay is costly" 1. Arm's Gregg LoCascio answered that Meta had moved from virtual-reality headsets to AI eyeglasses and adjusted its terms: "They were not harmed in the least" 1. Arm also argues Qualcomm leaked non-public details of antitrust investigations itself, and so cannot claim damages over a leak 2.

Nine percent of Arm's revenue rides on this fight

Qualcomm was 9% of Arm's total revenue in the fiscal year ended March 31, 2026 4. Arm's royalty growth leans on higher per-chip rates from newer architectures, and its own annual filing warns customers may refuse to pay them 4. Revenue rose 22% in the June quarter as data-center royalties more than doubled year over year, and the current quarter is guided higher still 6. ARM shares have gained about 168% this year; Qualcomm's about 6% 2.

Arm's revenue ramp runs into the trial, with the current quarter guided higher

  • Revenue
  • Estimate
$0.8B$1B$1.2B$1.4B$1.6BQ1 '24Q3 '24Q1 '25Q3 '25Q1 '26Q3 '26$1.38B$1.33–1.43B$1.29BQualcomm trial opened 5 Oct
Data
Revenue
Q1 '24$0.93B
Q2 '24$0.94B
Q3 '24$0.84B
Q4 '24$0.98B
Q1 '25$1.24B
Q2 '25$1.05B
Q3 '25$1.14B
Q4 '25$1.24B
Q1 '26$1.49B
Q2 '26$1.29B
Q3 '26 (estimate)$1.38B ($1.33–1.43B)
Total revenue by calendar quarter label; Arm's fiscal year ends March 31. US$ billions, from Arm's SEC filings. The final point is Arm's own guidance for the quarter ended September 30, 2026, marked as an estimate. Sources: [5][6].5,6

The trial runs five days, putting a verdict well before Arm reports on November 4 13. The 2022 case that started the feud remains on appeal 4. A jury that caps Arm's pricing would not break the 2033 agreement, but it would hand every other licensee the argument Qualcomm is making this week.

Deepdive

AI-generated from this story and its cited sources. Not investment advice.

Reader comments

0 comments

    Sign up

    Get your curated digest

    After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio